Progression-directed ablative radiotherapy improves event-free survival in oligoprogressive NSCLC. [PDF]
De Sanctis L +13 more
europepmc +1 more source
NED-oriented oncology in metastatic breast cancer: a hypothesis-driven framework integrating the tumor immune microenvironment, antibody-drug conjugates, and metastasis-directed therapy. [PDF]
Kashiwagi S.
europepmc +1 more source
Continuation of first-line therapy with progression-directed local therapy: a potential 1.5-line strategy bridging the gap between first- and second-line systemic therapy in oligoprogressive hepatocellular carcinoma. [PDF]
Zhang X, Yue J, Zhao L.
europepmc +1 more source
Oligometastatic disease and oligoprogression in gastrointestinal cancers
Trudy C. Wu, Krishan R. Jethwa
openaire +1 more source
Integrated Radiobiotherapy: A State-Based Framework for Response-Adaptive Combination Oncology. [PDF]
Vijayakumar S, Matrana M, Vijayakumar V.
europepmc +1 more source
Clinical outcomes and blood-based biomarkers across two SABR-treated metastatic settings: oligoprogression under immune checkpoint inhibition and oligometastatic disease. [PDF]
Zafra-Martin J +14 more
europepmc +1 more source
Salvage Metastasectomy After Adoptive Cell Transfer for Melanoma: Long-Term Updates. [PDF]
Dinerman AJ +14 more
europepmc +1 more source
Case Report: Exceptional long-term survival in metastatic pancreatic ductal adenocarcinoma after repeated high-dose hypofractionated lesion-directed radiotherapy. [PDF]
Ding M, Song Z, Di Y, Wang Y, Ren G.
europepmc +1 more source

